Related Experiment Video
Updated: Jan 7, 2026
X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
Aminopeptidase M17 in bacteria: insights into structure, function, and potential as a drug target
Hussam Askar1,2,3,4, Shengli Chen1,2,3, Huafang Hao1,2,3
1State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, China.
Abstract:
Leucyl-aminopeptidase (LAP) is a type of protease that targets peptides and the nitrogen terminus of protein molecules, playing a key role in the removal of amino acids. This function is not only significant but also enlightening, as it contributes to our understanding of microbial survival and persistence. The presence of M17-LAPs enzymes across various bacterial species indicates the possibility of creating selective inhibitors, offering new avenues for antimicrobial development amidst increasing antibiotic resistance. Additionally, understanding the relationship between the structure of these enzymes and their functions can aid in the development of more effective treatment methods and enhance current therapies. In this review, we unravel the structural blueprints, functional roles, and therapeutic promise of M17-LAPs, highlighting their relevance in the era of escalating antibiotic resistance. We also highlight future research avenues, emphasizing structural biology and protein-protein interaction mapping as keys to unlocking targeted therapeutic strategies. By bridging molecular structure with translational potential, we propose a new vision: harnessing the vulnerabilities of M17-LAPs to inspire next-generation antibacterial strategies.
Insights
Leucyl-aminopeptidase (LAP) enzymes are crucial for microbial survival. Targeting these M17-LAP enzymes offers a promising strategy for developing new antibiotics against resistant bacteria.
Area of Science:
- Biochemistry and Molecular Biology
- Microbiology
- Drug Discovery
Background:
- Leucyl-aminopeptidase (LAP) is a protease essential for amino acid removal and microbial survival.
- M17-LAP enzymes are present in diverse bacterial species, presenting potential targets for antimicrobial intervention.
- Rising antibiotic resistance necessitates novel therapeutic strategies.
Purpose of the Study:
- To review the structural characteristics, functional significance, and therapeutic potential of M17-LAP enzymes.
- To explore the role of M17-LAPs in bacterial persistence and their relevance in combating antibiotic resistance.
- To identify future research directions for developing targeted antibacterial therapies.
Main Methods:
- Literature review focusing on structural biology and functional analysis of M17-LAP enzymes.
- Analysis of protein-protein interactions to map potential therapeutic targets.
- Exploration of structure-function relationships for inhibitor design.
Main Results:
- M17-LAPs possess unique structural features that dictate their enzymatic activity and biological roles.
- Understanding these enzymes provides insights into microbial survival mechanisms.
- The study highlights the potential for selective M17-LAP inhibitors as novel antimicrobial agents.
Conclusions:
- M17-LAP enzymes represent a promising target for next-generation antibacterial strategies.
- Structural biology and protein interaction mapping are key to unlocking their therapeutic potential.
- Harnessing M17-LAP vulnerabilities can lead to innovative treatments for antibiotic-resistant infections.
Related Concept Videos
01:30Development of Antibiotic Resistance
01:23Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:28Peptidoglycan Synthesis